PRKCD and diabetic cardiomyopathy: In conclusion, we demonstrated that DATS exerts its cardioprotective effects against cardiac cell apoptosis by suppressing oxidative stress-induced PKCδ activation in both in vivo and in vitro studies, strongly suggesting that DATS could be a potential therapeutic agent for diabetic complications, such as diabetic cardiomyopathy.